Advancements in Personalized Cancer Therapies

Authors

  • Jesse Nelson
  • Harry Baker
  • Drew Young

Keywords:

cancer, personalized, therapy, genomics, clinical

Abstract

This article delves into the rapidly evolving field of personalized cancer therapies, which aim to tailor treatment based on individual genetic profiles. By leveraging advancements in genomic sequencing and molecular biology, personalized therapies promise to enhance treatment effectiveness and reduce adverse effects. This paper reviews recent clinical trials and case studies, demonstrating significant improvements in patient outcomes. However, challenges such as high costs and the need for robust infrastructure remain. The future of oncology is poised to be revolutionized by personalized medicine, but widespread implementation requires overcoming current limitations.

This is a free preview. The complete article is available with a valid subscription.

Author Biographies

Jesse Nelson

PhD
Massachusetts Institute of Technology
77 Massachusetts Ave, Cambridge, MA 02139, USA

Harry Baker

MD
University of Oxford
Oxford OX1 2JD, United Kingdom

Drew Young

PhD
Lviv Polytechnic National University
S. Bandery St, 12, Lviv, Lviv Oblast, Ukraine, 79000

References

Viroliya, K., Hojjat, A., Pena, B., Bhatt, H., Mehta, N. N., Venkata, S. Y., ... & Palabindela, P. (2023). Sa1359 HELICOBACTER PYLORI ASSOCIATED GASTRO-INTESTINAL BLEEDING IN BARIATRIC SURGERY-NATIONWIDE SURREY. Gastroenterology, 164(6), S-373.

Published

2025-11-03

Issue

Section

Articles